BGMS
Bio Green Med Solution, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$0.90
−1.96%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +73.8%
- EBIT
- +73.6%
- EPS
- +98.8%
- Free cash flow
- +87.4%
- Operating cash flow
- +87.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +33.4%
- EBITDA
- +29.8%
- EBIT
- +29.8%
- Net income
- +73.3%
- EPS
- +98.7%
- Free cash flow
- +40.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026